Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a)

FEBS Letters

Volumn 587, Issue 16, 2013, Pages 2623-2628

  Stead, Rebecca L ^a   Proud, Christopher G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

eIF4E; Mnk; mTORC1; Rapamycin

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INTERACTING KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INTERACTING KINASE 2A; RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FIBROBLAST; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EIF4E; MNK; MTORC1; RAPAMYCIN;

ALANINE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-4E; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANOSINE TRIPHOSPHATE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SERINE; SIROLIMUS;

EUKARYOTA;

EID: 84881478230     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.06.045     Document Type: Article

References (36)

1. J.R. Graff, B.W. Konicek, J.H. Carter, and E.G. Marcusson Targeting the eukaryotic translation initiation factor 4E for cancer therapy Cancer Res. 68 2008 631 634
2. J. Hou, F. Lam, C. Proud, and S. Wang Targeting mnks for cancer therapy Oncotarget 3 2012 118 131
3. A. Lazaris-Karatzas, K.S. Montine, and N. Sonenberg Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5 cap Nature 345 1990 544 547
4. D. Ruggero, L. Montanaro, L. Ma, W. Xu, P. Londei, C. Cordon-Cardo, and P.P. Pandolfi The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis Nat. Med. 10 2004 484 486
5. H.G. Wendel, E. De Stanchina, J.S. Fridman, A. Malina, S. Ray, S. Kogan, C. Cordon-Cardo, J. Pelletier, and S.W. Lowe Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy Nature 428 2004 332 337
6. J. Averous, and C.G. Proud When translation meets transformation: the mTOR story Oncogene 25 2006 6423 6435
7. J. Huang, and B.D. Manning The TSC1-TSC2 complex: a molecular switchboard controlling cell growth J. Biochem. 412 2008 179 190
8. C.G. Proud Signalling to translation: how signal transduction pathways control the protein synthetic machinery J. Biochem. 403 2007 217 234
9. C. Battelli, and D.C. Cho MTOR inhibitors in renal cell carcinoma Therapy 8 2011 359 367
10. M.E. Feldman, B. Apsel, A. Uotila, R. Loewith, Z.A. Knight, D. Ruggero, and K.M. Shokat Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2 PLoS Biol. 7 2009 e38
11. C.C. Thoreen, S.A. Kang, J.W. Chang, Q. Liu, J. Zhang, Y. Gao, L.J. Reichling, T. Sim, D.M. Sabatini, and N.S. Gray An ATP-competitive mTOR inhibitor reveals rapamycin-insensitive functions of mTORC1 J. Biol. Chem. 284 2009 8023 8032
12. C.M. Chresta, B.R. Davies, I. Hickson, T. Harding, S. Cosulich, S.E. Critchlow, J.P. Vincent, R. Ellston, D. Jones, P. Sini, D. James, Z. Howard, P. Dudley, G. Hughes, L. Smith, S. Maguire, M. Hummersone, K. Malagu, K. Menear, R. Jenkins, M. Jacobsen, G.C. Smith, S. Guichard, and M. Pass AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity Cancer Res. 70 2010 288 298
13. A. Flynn, and C.G. Proud Serine 209, not serine 53, is the major site of phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cells J. Biol. Chem. 270 1995 21684 21688
14. B. Joshi, A.L. Cai, B.D. Keiper, W.B. Minich, R. Mendez, C.M. Beach, R. Stolarski, E. Darzynkiewicz, and R.E. Rhoads Phosphorylation of eukaryotic protein synthesis initiation factor 4E at serine 209 J. Biol. Chem. 270 1995 14597 14603
15. A.J. Waskiewicz, A. Flynn, C.G. Proud, and J.A. Cooper Mitogen-activated kinases activate the serine/threonine kinases Mnk1 and Mnk2 EMBO J. 16 1997 1909 1920
16. R. Fukunaga, and T. Hunter Mnk1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates EMBO J. 16 1997 1921 1933
17. X. Wang, A. Flynn, A.J. Waskiewicz, B.L.J. Webb, R.G. Vries, I.A. Baines, J. Cooper, and C.G. Proud The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses and cytokines is mediated by distinct MAP kinase pathways J. Biol. Chem. 273 1998 9373 9377
18. A.J. Waskiewicz, J.C. Johnson, B. Penn, M. Mahalingam, S.R. Kimball, and J.A. Cooper Phosphorylation of the cap-binding protein eukaryotic translation factor 4E by protein kinase Mnk1 in vivo Mol. Cell. Biol. 19 1999 1871 1880
19. J.L. Parra, M. Buxade, and C.G. Proud Features of the catalytic domains and C termini of the MAPK signal-integrating kinases Mnk1 and Mnk2 determine their differing activities and regulatory properties J. Biol. Chem. 280 2005 37623 37633
20. G.C. Scheper, J.L. Parra, M. Wilson, K.B. van, A.C. Vertegaal, Z.G. Han, and C.G. Proud The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization Mol. Cell. Biol. 23 2003 5692 5705
21. G.C. Scheper, N.A. Morrice, M. Kleijn, and C.G. Proud The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells Mol. Cell. Biol. 21 2001 743 754
22. L. Furic, L. Rong, O. Larsson, I.H. Koumakpayi, K. Yoshida, A. Brueschke, E. Petroulakis, N. Robichaud, M. Pollak, L.A. Gaboury, P.P. Pandolfi, F. Saad, and N. Sonenberg EIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression Proc. Natl. Acad. Sci. USA 107 2010 14134 14139
23. T. Ueda, M. Sasaki, A.J. Elia, I.I. Chio, K. Hamada, R. Fukunaga, and T.W. Mak Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development Proc. Natl. Acad. Sci. USA 107 2010 13984 13990
24. H.G. Wendel, R.L. Silva, A. Malina, J.R. Mills, H. Zhu, T. Ueda, R. Watanabe-Fukunaga, R. Fukunaga, J. Teruya-Feldstein, J. Pelletier, and S.W. Lowe Dissecting eIF4E action in tumorigenesis Genes Dev. 21 2007 3232 3237
25. X. Wang, P. Yue, C.B. Chan, K. Ye, T. Ueda, R. Watanabe-Fukunaga, R. Fukunaga, H. Fu, F.R. Khuri, and S.Y. Sun Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation Mol. Cell. Biol. 27 2007 7405 7413
26. M. Marzec, X. Liu, M. Wysocka, A.H. Rook, N. Odum, and M.A. Wasik Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells PLoS One 6 2011 e24849
27. C. Zang, J. Eucker, H. Liu, A. Muller, K. Possinger, and C.W. Scholz Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1 Cancer Lett. 2012
28. A. Bianchini, M. Loiarro, P. Bielli, R. Busa, M.P. Paronetto, F. Loreni, R. Geremia, and C. Sette Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells Carcinogenesis 29 2008 2279 2288
29. S.Y. Sun, L.M. Rosenberg, X. Wang, Z. Zhou, P. Yue, H. Fu, and F.R. Khuri Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition Cancer Res. 65 2005 7052 7058
30. B.D. Stern, M. Wilson, and R. Jagus Use of nonreducing SDS-PAGE for monitoring renaturation of recombinant protein synthesis initiation factor, eIF-4 alpha Protein Expr. Purif. 4 1993 320 327
31. B.D. Fonseca, T. Alain, L.K. Finestone, B.P. Huang, M. Rolfe, T. Jiang, Z. Yao, G. Hernandez, C.F. Bennett, and C.G. Proud Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90RSK in the control of mTORC1 protein signaling by phorbol esters J. Biol. Chem. 286 2011 27111 27122
32. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 77 1976 248 254
33. S. Goto, Z. Yao, and C.G. Proud The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity J. Biol. Chem. 423 2009 279 290
34. S. Pyronnet, H. Imataka, A.C. Gingras, R. Fukunaga, T. Hunter, and N. Sonenberg Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E EMBO J. 18 1999 270 279
35. Y. Huo, V. Iadevaia, Z. Yao, I. Kelly, S. Cosulich, S. Guichard, L.J. Foster, and C.G. Proud Stable isotope-labelling analysis of the impact of inhibition of the mammalian target of rapamycin on protein synthesis J. Biol. Chem. 444 2012 141 151
36. T. Ueda, R. Watanabe-Fukunaga, H. Fukuyama, S. Nagata, and R. Fukunaga Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development Mol. Cell. Biol. 24 2004 6539 6549